TABLE 1.
Procedure | Baseline Visit* | Visit 2* 24‐30mo | Visit 3* 48‐60mo |
---|---|---|---|
Interview | X | X | X |
Functional Exam | X | X | X |
Cognitive Battery | X | X | X |
Physical Exam | X | X | X |
Informant Interview | X | X | X |
Blood Draw | X | X | X |
Proteomics | X | X | X |
Exosome assays | X | X | |
MRI | X | X | X |
Amyloid PET | X | X | |
Tau PET | X | X | |
Consensus Classification | X | X | X |
Waves of the HABLE protocol are scheduled for ≈24 month follow‐up timepoints. Due to coronavirus diseases 2019 (COVID‐19), completion of ongoing Wave 1 as well as Wave 2 assessments was longer.